It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. 

Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name.

Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."

AdvaMed, a medtech industry group made up of medical imaging companies, says tariffs are having a major impact for all vendors. 

For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing.